Navigation Links
Top cancer specialists receive ESMO awards
Date:9/15/2010

Lugano, 15 September 2010 -- The European Society for Medical Oncology (ESMO) honors three eminent cancer specialists for their contribution to the advancement of medical research. The awards will be presented to Hilary Calvert, Alberto Costa and Bengt Glimelius at the 35th ESMO Congress, to take place from 8-12 October in Milan, Italy.

Dr Alberto Costa will be presented with the 2010 ESMO Award for his key role in the development of international guidelines for breast cancer and his ongoing commitment to the education of oncologists. This distinction is conferred on an ESMO member who has made an outstanding contribution to the development of oncology in Europe and who recognizes the importance of promoting oncology as a specialty within the international community.

Dr Costa's many achievements include participation in the famous Milan Trial (local control and survival in early breast cancer), in the St. Gallen Consensus Report, and the development of chemoprevention. Scientific communication has also been an important part of his work.

On the current standard of care for breast cancer patients in Europe, Dr Costa highlights "the European concept of multidisciplinary care, which makes treatment safer. Europe also has the advantage of public national health so there is less inequality than in other parts of the world". Last but not least, Dr Costa has supported various patient advocacy groups including the well-known 'Europa Donna' cancer coalition. "Patients nowadays are very aware and have a huge amount of information. Their participation in groups helps improve practice for example by helping us rewrite the 'informed consent letters' in a comprehensible language. Patients have also helped us to understand that oncologists need to improve their communications skills."

Dr Alberto Costa is currently the Coordinator of the Breast Surgery Unit at the Maugeri Foundation in Pavia, Italy, and Coordinator of the Canton Ticino B
'/>"/>

Contact: Vanessa Pavinato
media@esmo.org
European Society for Medical Oncology
Source:Eurekalert

Page: 1 2 3 4

Related biology news :

1. Molecule identified that increases survival of stomach cancer patients
2. Muscle wasting in cancer does not spare the heart
3. Biologists find way to reduce stem cell loss during cancer treatment
4. Connection between light at night and cancer revealed in additional study
5. Connection between light at night (LAN) and cancer revealed in additional study
6. New infrared light may open new frontier in fighting cancer, Tay Sachs
7. High-fat diet during puberty linked to breast cancer risk later in life
8. Researchers to activate anti-cancer gene
9. Researcher finds revolutionary way to treat eye cancer
10. Microneedle, quantum dot study opens door to new clinical cancer tools
11. LOreal Fellowship winner seeks to understand breast cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/10/2014)... , Dec. 9, 2014  Valencell, a leader in ... seeing a staggering demand from its licensees for highly ... revealed, is not solely coming from fitness and health ... "A wearable is only as useful as ... is the ultimate driver in long-term mass consumer adoption ...
(Date:12/10/2014)... California , December 9, 2014 ... with ITN,s BCARD Platform   ... cloud-based enterprise meeting scheduling solutions for business-to-business (B2B) ... the world leader in mobile near-field communication (NFC), ...      (Logo: http://photos.prnewswire.com/prnh/20140612/691055) , ...
(Date:12/3/2014)... Calif. , Dec. 2, 2014   ... globally deployed, innovative test solutions for military, aerospace, ... newest version of its successful TS-900 PXI ... performance and features of high-end systems to customers ... outstanding value compared to traditional ATE. ...
Breaking Biology News(10 mins):Wearable Technology Products Demand Highly Accurate Biometric Technology 2Jifflenow And ITN International Bring Cutting-Edge Badge Scanning Technology To B2B Events 2Jifflenow And ITN International Bring Cutting-Edge Badge Scanning Technology To B2B Events 3Marvin Test Solutions Brings New Capabilities to PXI-Based Semiconductor Test with TS-960 2Marvin Test Solutions Brings New Capabilities to PXI-Based Semiconductor Test with TS-960 3
... researchers at the Department of Energy,s BioEnergy Science Center ... ethanol production capacity in a microorganism. This discovery could ... produce higher concentrations of ethanol at lower costs. ... scientific discoveries of its labs and research centers to ...
... of General Medical Sciences, part of the National Institutes ... Infectious Disease Agent Study for a research project at ... Stephen Eubank, professor. Infectious diseases pose one of ... Models of Infectious Disease Agent Study (MIDAS) is a ...
... essential in the fight against,breast cancer. As described in ... this organ represents an excellent model system for investigation ... body. The branching morphogenesis that occurs during puberty and ... that occur in many tissues during embryogenesis and are ...
Cached Biology News:Single, key gene discovery could streamline production of biofuels 2National Institutes of Health renews successful infectious disease research study 2National Institutes of Health renews successful infectious disease research study 3
(Date:12/24/2014)... PARIS and NEW YORK ... data from its open-label pilot study of mazindol in ... Design, Development and Therapy in December 2014 . ... of mazindol in children with attention deficit/hyperactivity disorder" ( ... 2014 Dec 1;8:2321-2332. eCollection 2014 ) ...
(Date:12/22/2014)... HILL, N.C. , Dec. 22, 2014 /PRNewswire/ ... today announced that it has signed a letter ... company that has developed and patented a nanotechnology-based ... medical diagnostics products that enable rapid on-site collection ... alcohol use/abuse and health issues in an immediate, ...
(Date:12/22/2014)... Chicago, Illinois (PRWEB) December 22, 2014 ... representing tenants and occupiers of commercial real estate, has ... two new offices in Perth and Brisbane, Western Australia, ... board of directors. , ITRA Global / ACORPP ... and totally independent consultancy company providing property services to ...
(Date:12/19/2014)... 19, 2014 BioPlus Specialty Pharmacy ... announces the promotion of Nick Maroulis, Pharm.D. to the ... Services. , In this position, Dr. Maroulis will ... managing the directors of our multi-site pharmacies as the ... 1997 and during that time he has served in ...
Breaking Biology Technology:Redefining ADHD: A New Approach & A Shift of Paradigm in ADHD Therapeutics 2Redefining ADHD: A New Approach & A Shift of Paradigm in ADHD Therapeutics 3ALNE Announces Intention To Acquire BioTechPharma 2ITRA Global Continues International Expansion in Perth and Brisbane, Australia 2BioPlus Specialty Pharmacy Promotes Dr. Nick Maroulis to Vice President of Specialty Pharmacy Services 2
... Oct. 21 (11:00 PM PT,Oct. 20) -- ... that,Novartis AG has agreed to acquire from Nektar ... $115 million in cash., "This agreement will ... development,of novel therapeutics using our PEGylation and conjugate ...
... riddled with defects, bulk crystalline materials never achieve their ... small there,s no room for defects. ("Nano" is short ... nanocrystalline materials may approach ideal strength in their resistance ... ability to withstand large internal strains before they fail. ...
... With limited information on,actual return on ... Education activities, pharmaceutical, biotechnology and medical,device industry ... of CME,support and strategies for ensuring investments ... patient outcomes. In the recently,published report by ...
Cached Biology Technology:Nektar Sells Pulmonary Business to Novartis For $115 Million and Nektar Retains Key Pulmonary Programs Including Amikacin Inhale, Inhaled Vancomycin, and Ciprofloxacin Inhalation Powder 2Nektar Sells Pulmonary Business to Novartis For $115 Million and Nektar Retains Key Pulmonary Programs Including Amikacin Inhale, Inhaled Vancomycin, and Ciprofloxacin Inhalation Powder 3Nektar Sells Pulmonary Business to Novartis For $115 Million and Nektar Retains Key Pulmonary Programs Including Amikacin Inhale, Inhaled Vancomycin, and Ciprofloxacin Inhalation Powder 4Engineering nanoparticles for maximum strength 2Engineering nanoparticles for maximum strength 3Engineering nanoparticles for maximum strength 4Bio-Pharma Industry Improves Patient Outcomes Through Continuing Medical Education (CME) 2
Glucagon-like peptide-1 (GLP-1 (1-36) amide)...
Complement factor B (human)...
... JNK (c-Jun NH2-terminal kinase) signal transduction ... MAP kinase pathways in mammals. JNK ... environmental stress, is associated with the ... is implicated in the immune response, ...
... far-infrared range FT-IR spectrometers give you the ... Yet all this comes at an amazingly ... Having a larger and faster mirror closer ... FT-IRs provides 300%,larger solid angle of energy ...
Biology Products: